7Baggers
 Cardiopulmonary drugmaker Inhibikase Therapeutics' Q3 net loss widens  MarketScreener Fri, 14 Nov 2025 21:11:25 GMT
 will inhibikase therapeutics inc. stock recover after recent drop  newser.com Tue, 04 Nov 2025 09:53:18 GMT

Inhibikase Therapeutics, Inc
(NASDAQ:IKT) 

IKT stock logo

Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease, and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a c-Abl protein kinase inhibitor for use in the treatment of P...

Founded: 2008
CEO: Dr. Milton Werner  
Sector:
Industry:

Share this website to your friends